GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–60. https://doi.org/10.1016/S2214-109X(20)30489-7.

Article  Google Scholar 

Miller DJ, Cascio MA, Rosca MG. Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease. Antioxidants (Basel). 2020;9(10):905. https://doi.org/10.3390/antiox9100905.

Article  CAS  PubMed  Google Scholar 

Barrera-Guarderas F, Flor AP, Coba-Loor S, Chacón-Andrade K. Diabetic retinopathy: long term follow-up of Ecuadorian patients with type 2 diabetes in primary care. Int J Diabetes Dev Ctries. 2023;43:441–7. https://doi.org/10.1007/s13410-022-01109-9.

Article  CAS  Google Scholar 

Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322–5. https://doi.org/10.1111/jdi.13480.

Article  PubMed  PubMed Central  Google Scholar 

Teo Z, Tham Y, Yu M, Chee M, Rim T, Wong T, Cheng C, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J]. Ophthalmology. 2021;128(11):1580–91. https://doi.org/10.1016/j.ophtha.2021.04.027.

Article  PubMed  Google Scholar 

Pandova MG. Diabetic Retinopathy and Blindness: an epidemiological overview. In: Giudice GL, Catalá A, editors. Visual impairment and blindness-what we know and what we have to know. IntechOpen; 2019. https://doi.org/10.5772/intechopen.88756.

Yang QH, Zhang Y, Zhang XM, Li XR. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non proliferative diabetic retinopathy in Asian type 2 diabetesM patients: a systematic review and Meta-analysis. Int J Ophthalmol. 2019;12:302–11. https://doi.org/10.18240/ijo.2019.02.19.

Article  PubMed  PubMed Central  Google Scholar 

Hou X, Wang L, Zhu D, Guo L, Weng J, Jia W, China National Diabetic Chronic Complications (DiaChronic) Study Group, et al. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China. Nat Commun. 2023;14(1):4296. https://doi.org/10.1038/s41467-023-39864-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14(1):21–42. https://doi.org/10.1007/s13167-023-00314-8.

Article  PubMed  PubMed Central  Google Scholar 

Agarwal M, Rani PK, Raman R, et al. Diabetic retinopathy screening guidelines for Physicians in India: position statement by the Research Society for the Study of Diabetes in India (RSSDI) and the Vitreoretinal Society of India (VRSI)-2023. Int J Diabetes Dev Ctries. 2024;44:32–9. https://doi.org/10.1007/s13410-023-01296-z.

Article  Google Scholar 

Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Diabetic retinopathy preferred practice pattern®. Ophthalmology. 2020;127(1):P66–145. https://doi.org/10.1016/j.ophtha.2019.09.025.

Article  PubMed  Google Scholar 

Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, et al. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e001923. https://doi.org/10.1136/bmjdrc-2020-001923.

Article  PubMed  PubMed Central  Google Scholar 

Raman R, Vasconcelos JC, Rajalakshmi R, Prevost AT, Ramasamy K, SMART India Study Collaborators, et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban-rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study. Lancet Glob Health. 2022;10(12):e1764–73. https://doi.org/10.1016/S2214-109X(22)00411-9.

Article  CAS  PubMed  Google Scholar 

Whyte MB, Joy M, Hinton W, McGovern A, Hoang U, van Vlymen J, et al. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study. Diabetes Obes Metab. 2022;24(7):1310–8. https://doi.org/10.1111/dom.14705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Funamizu T, Iwata H, Nishida Y, Miyosawa K, Doi S, Chikata Y, et al. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study. Cardiovasc Diabetol. 2020;19(1):21. https://doi.org/10.1186/s12933-020-00996-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCoy RG, Faust L, Heien HC, Patel S, Caffo B, Ngufor C. Longitudinal trajectories of glycemic control among U.S. Adults with newly diagnosed diabetes. Diabetes Res Clin Pract. 2023;205:110989. https://doi.org/10.1016/j.diabres.2023.110989.

Article  CAS  PubMed  Google Scholar 

Pei J, Wang X, Pei Z, Hu X. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study. Cardiovasc Diabetol. 2023;22(1):287. https://doi.org/10.1186/s12933-023-02026-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skriver MV, Sandbæk A, Kristensen JK, Støvring H. Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study. BMJ Open Diabetes Res Care. 2015;3(1):e000060. https://doi.org/10.1136/bmjdrc-2014-000060.

Article  PubMed  PubMed Central  Google Scholar 

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Collaborators developing the Japanese equation for estimated GFR, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92. https://doi.org/10.1053/j.ajkd.2008.12.034.

Article  CAS  PubMed  Google Scholar 

Expert Group of Chinese Society of Nephrology. Chinese guidelines for diagnosis and treatment of diabetic kidney disease. Chin J Nephrol. 2021;37(3):255–304. https://doi.org/10.3760/cma.j.cn441217-20201125-00041.

Article  Google Scholar 

Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. 2020;382(17):1629–37. https://doi.org/10.1056/NEJMra1909637.

Article  CAS  PubMed  Google Scholar 

Ma C, Zhang W, Xie R, Wan G, Yang G, Zhang X, et al. Effect of hemoglobin A1c trajectories on future outcomes in a 10-year cohort with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022;13:846823. https://doi.org/10.3389/fendo.2022.846823.

Article  PubMed  Google Scholar 

Wu TE, Su YW, Chen HS. Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2022;192:110069. https://doi.org/10.1016/j.diabres.2022.110069.

Article  CAS  PubMed  Google Scholar 

Simó R, Franch-Nadal J, Vlacho B, Real J, Amado E, Flores J, et al. Rapid reduction of HbA1c and early worsening of diabetic retinopathy: a real-world population-based study in subjects with type 2 diabetes. Diabetes Care. 2023;46(9):1633–9. https://doi.org/10.2337/dc22-2521.

Article  CAS  PubMed  Google Scholar 

Laiteerapong N, Karter AJ, Moffet HH, Cooper JM, Gibbons RD, Liu JY, et al. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study. J Diabetes Complications. 2017;31(1):94–100. https://doi.org/10.1016/j.jdiacomp.2016.07.023.

Article  PubMed  Google Scholar 

Feldman-Billard S, Larger É, Massin P, Standards for screeningand surveillance of ocular complications in people with diabetes SFD study group. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab. 2018;44(1):4–14. https://doi.org/10.1016/j.diabet.2017.10.014.

Article  CAS  PubMed  Google Scholar 

Hu J, Hsu H, Yuan X, Lou K, Hsue C, Miller JD, Lou Q, et al. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes. J Endocrinol Invest. 2021;44(6):1229–36. https://doi.org/10.1007/s40618-020-01410-6.

Article  CAS  PubMed  Google Scholar 

Tang F, Wang W, Wang Y, Lee Y, Lou Q. Moderate resistance training reduces intermuscular adipose tissue and risk factors of atherosclerotic cardiovascular disease for elderly patients with type 2 diabetes. Diabetes Obes Metab. 2024;26(8):3418–28. https://doi.org/10.1111/dom.15684.

Article  CAS  PubMed